SCHEMBL4775765

SCHEMBL4775765

NC(C=O)N1CC=C(c2ccccc2CN2CCOCC2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 5/20 0.40
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
BRD4 O60885 1/20 0.39
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 1/20 0.37
CYP2C9 P11712 2/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PIK3CD O00329 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
ERN1 O75460 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27723069 0.87 CYP2A13 (0.39) CYP2A13ADORA2AADORA1BRD4ALDH1A1
SCHEMBL27723067 0.81 ALDH1A1 (0.40) CYP2A13ADORA2AADORA1BRD4ALDH1A1
SCHEMBL4837899 0.75 NAMPT (0.46) CYP2A13ADORA2AADORA1BRD4ALDH1A1
SCHEMBL4779407 0.72 NAMPT (0.46) CYP2A13BRD4ALDH1A1KMT2AKDM4E
SCHEMBL4775570 0.72 AKR1C3 (0.42) CYP2A13
Hydrochloric Acid SCHEMBL9423982 0.67 CYP2A13 (0.62) CYP2A13ADORA2AADORA1ALDH1A1KMT2A
SCHEMBL2002333 0.66 CYP2A13 (0.50) CYP2A13ADORA2AADORA1BRD4ALDH1A1
SCHEMBL11193326 0.66 CYP2A13 (0.75) CYP2A13ALDH1A1KMT2AKDM4EMAPT
SCHEMBL29415418 0.66 HTR7 (0.69) CYP2A13ADORA2AADORA1ALDH1A1KMT2A
SCHEMBL28195866 0.66 HTR7 (0.69) CYP2A13ADORA2AADORA1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996550-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES Novartis AG (CH) 2008-12-03 EP claimed
WO-2007038459-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES NOVARTIS AG (CH) 2007-04-05 WO claimed
EP-1996550-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES Novartis AG (CH) 2008-12-03 EP disclosed
WO-2007038459-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES NOVARTIS AG (CH) 2007-04-05 WO disclosed